2-(3-chloro-7-((6-fluoroquinazolin-2-yl)(methyl)amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)acetic acid | 1403367-27-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 2-(3-chloro-7-((6-fluoroquinazolin-2-yl)(methyl)amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)acetic acid
• 英文别名: 2-[3-Chloro-7-[(6-fluoroquinazolin-2-yl)-methylamino]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetic acid
• CAS: 1403367-27-0
• 化学式: C₂₃H₂₀ClFN₄O₂
• 分子量: 438.889
• InChiKey: CEWBFBFOCXBKSB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  31
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  71.2
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• [EN] 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS D'ACIDE 7-(HÉTÉROARYL-AMINO)-6,7,8,9-TÉTRAHYDROPYRIDO[1,2-A]INDOLACÉTIQUE ET LEUR UTILISATION EN TANT QUE MODULATEURS DU RÉCEPTEUR AUX PROSTAGLANDINES D2
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2012140612A1

  公开（公告）日：2012-10-18

  The present invention relates to 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives of the formula (I), wherein R1, R2, R3 and R4 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.

  本发明涉及公式（I）中的7-(杂环芳基氨基)-6,7,8,9-四氢吡啶并[1,2-a]吲哚乙酸衍生物，其中R1、R2、R3和R4如描述中所述，并且它们作为前列腺素受体调节剂，尤其作为前列腺素D2受体调节剂，在治疗各种前列腺素介导的疾病和紊乱中的用途，以及包含这些化合物的药物组合物和其制备方法。
• 7-(Heteroaryl-Amino)-6,7,8,9-Tetrahydropyrido[1,2-A]Indol Acetic Acid Derivatives and Their Use as Prostaglandin D2 Receptor Modulators
  申请人：Aissaoui Hamed

  公开号：US20140045870A1

  公开（公告）日：2014-02-13

  The present invention relates to 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives of the formula (I), wherein R 1 , R 2 , R 3 and R 4 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin D 2 receptor modulators, in the treatment of various prostaglandin-mediated diseases and disorders, to pharmaceutical compositions containing these compounds and to processes for their preparation.

  本发明涉及式(I)的7-(杂环芳基氨基)-6,7,8,9-四氢吡啶[1,2-a]吲哚乙酸衍生物，其中R1、R2、R3和R4如描述中所述，以及它们作为前列腺素受体调节剂的用途，特别是作为前列腺素D2受体调节剂，在治疗各种前列腺素介导的疾病和紊乱中使用，以及含有这些化合物的制药组合物和其制备方法。
• 7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
  申请人：Actelion Pharmaceuticals Ltd.

  公开号：EP2697223A1

  公开（公告）日：2014-02-19
• US9096595B2
  申请人：——

  公开号：US9096595B2

  公开（公告）日：2015-08-04